Healthcare spending in the U.S. surged by 7.5% to $4.9 trillion in 2023, with prescription drug use and Affordable Care Act enrollments driving the rise, a government report revealed. The sector accounted for 17.6% of the U.S. economy, reflecting its growing financial impact.
Affordable Care Act Plans Drive Healthcare Spending Surge
According to a research released on Wednesday by the Centers for Medicare and Medicaid Services, private health plan membership, especially those covered by the Affordable Care Act, drove a 7.5% increase in U.S. healthcare spending in 2023, reaching $4.9 trillion, Investing.com shares.
Medicare, the federal program that provides health insurance to those 65 and older or who are disabled, has reported that healthcare spending has surpassed economic growth in the United States. Compared to GDP growth of 2.9% in 2023, it increased by an inflation-adjusted 4.4%, according to the research.
Per a CMS official who spoke at a press event, retail prescription medication spending increased the most, by 11.4% to $449.7 billion, following a 7.8% increase in 2022. This increase was mostly caused by the usage of drugs for diabetes and weight reduction.
Prescription Drug Costs Skyrocket in 2023
According to the official, the amount spent on diabetic medications, including the newer GLP-1 medications like Ozempic and Wegovy, which are also used for weight loss, rose by 35% under the Medicare prescription drug program.
"That significantly contributed to Medicare prescription drug spending growth of 12.2%," according to the official.
In 2023, healthcare accounted up 17.6% of the U.S. economy, a small increase from 17.4% the previous year. The report stated that this percentage is somewhat lower than when the COVID-19 epidemic was at its peak.
In 2023, healthcare spending reached $1.5 trillion, an increase of 10.4 percent, the greatest growth rate in almost 30 years. Clinical service spending went up 7.4 percent.
Commercial Insurers Dominate U.S. Healthcare Costs
The biggest portion of the budget went to commercial insurers, with their share increasing from 19.5% in 2022 to 30% in 2023 as a result of more people enrolling in employer-sponsored health plans and more people enrolling in ACA plans, also known as Obamacare.
Premiums for Obamacare enrollees were lowered by improved subsidies contained in the 2021 American Rescue Plan Act and the 2022 Inflation Reduction Act. More than 2.7% of the population enrolled in an Obamacare plan in 2023, after those policies were introduced.
The CMS states that 3.3 million Americans, or 1.6% of the total population, enrolled in private health insurance in 2023.
Health Insurance Coverage Reaches New High
According to the research, the percentage of Americans with health insurance increased to 92.5% in 2023 from 92.0% in 2022.


New Zealand Budget Outlook Shows Prolonged Deficits Despite Economic Recovery Hopes
Asian Currencies Trade Sideways as Dollar Weakens Ahead of Key U.S. Data
Korea Zinc to Build $7.4 Billion Critical Minerals Refinery in Tennessee With U.S. Government Backing
Asian Stocks Slide as Central Bank Decisions and Key Data Keep Investors Cautious
Gold and Silver Surge as Safe Haven Demand Rises on U.S. Economic Uncertainty
Singapore Growth Outlook Brightens for 2025 as Economists Flag AI and Geopolitical Risks
Chinese Robotaxi Stocks Rally as Tesla Boosts Autonomous Driving Optimism
Japan Exports to U.S. Rebound in November as Tariff Impact Eases, Boosting BOJ Rate Hike Expectations
South Korea Warns Weak Won Could Push Inflation Higher in 2025
Oil Prices Rebound as U.S.-Venezuela Tensions Offset Oversupply Concerns
Trump Orders Blockade of Sanctioned Oil Tankers, Raising Venezuela Tensions and Oil Prices
U.S. Dollar Slips Near Two-Month Low as Markets Await Key Jobs Data and Central Bank Decisions
Bank of Korea Downplays Liquidity’s Role in Weak Won and Housing Price Surge
Wall Street Futures Slip as Tech Stocks Struggle Ahead of Key US Economic Data
Oil Prices Slip in Asia as 2026 Supply Glut Fears and Russia-Ukraine Talks Weigh on Markets
Gold and Silver Prices Dip as Markets Await Key U.S. Economic Data 



